Inventor · disambiguated record
Erica Ollmann Saphire
Also filed as: SAPHIRE ERICA · SAPHIRE ERICA O · SAPHIRE ERICA OLLMANN
4 granted patents·13 pending applications·1 citations·filing 2015–2023
60Inventor score
Files withLA JOLLA INST FOR IMMUNOLOGY10THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND3UNIV EMORY2BERRY JODY1INTEGRATED BIOTHERAPEUTICS INC1
Top patents by PatentIndex Score
17 records- 0185US11713349B2Ebola virus antibodies and binding agents derived therefromUNIV EMORY·Filed 2021·Granted Aug 1, 2023·1 cites·20 claims
- 0281US12358971B2Arena virus monoclonal antibodies and usesTHE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND·Filed 2023·Granted Jul 15, 2025·0 cites·20 claims
- 0380US12329992B2Ebola virus antibodies and binding agents derived therefromUNIV EMORY·Filed 2023·Granted Jun 17, 2025·0 cites·11 claims
- 0465US2022089696A1Arenavirus monoclonal antibodies and usesTHE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND·Filed 2021·Application pending·0 cites
- 0555US11198723B2Arenavirus monoclonal antibodies and usesTHE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND·Filed 2017·Granted Dec 14, 2021·0 cites·13 claims
- 0652US2025381265A1Coronavirus Spike Glycoprotein With Improved Expression and StabilityLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 0747US2024425550A1Engineered rabies virus glycoprotein, compositions, and methods of use thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 0846US2025382353A1Anti-sars-cov2 spike (s) antibodies and uses thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2023·Application pending·0 cites
- 0944US2024239844A1Combinations of viral proteins, peptide sequences, epitopes, and methods and uses thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 1043US2023235029A1Broadly neutralizing binding molecules against marburgvirusesINTEGRATED BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1142US2025320278A1Chimeric anti-sars-cov2 nucleoprotein antibodiesLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 1242US2023310568A1Engineered arenavirus glycoprotein compositions and methods of use thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 1341US2024301037A1Chimeric anti-coronavirus spike protein antibodiesLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 1441US2025034213A1Engineered arenavirus glycoprotein compositions, methods and use thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 1540US2023391855A1Chimeric anti-sars-cov2 nucleoprotein antibodiesLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 1639US2023293673A1Methods for treating and preventing cytomegalovirus infectionLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 1731US2017226192A1Methods of modulating an immune responseBERRY JODY·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Erica Ollmann Saphire files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →